High Risk Localized Prostate Cancer clinical trials

Explore recruiting high risk localized prostate cancer clinical trials.

Recruiting high risk localized prostate cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

High Risk Localized Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PEACE2 : A randomized Phase III, factorial design, of cabazitaxel and pelvic radiotherapy in patients with localized prostate cancer and high-risk features of relapse

Belgium, France, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

High Risk Localized Prostate Cancer trials by city

High Risk Localized Prostate Cancer in Toronto High Risk Localized Prostate Cancer in Vancouver High Risk Localized Prostate Cancer in Montreal High Risk Localized Prostate Cancer in Calgary High Risk Localized Prostate Cancer in Edmonton High Risk Localized Prostate Cancer in Ottawa High Risk Localized Prostate Cancer in Winnipeg High Risk Localized Prostate Cancer in Quebec City High Risk Localized Prostate Cancer in Hamilton High Risk Localized Prostate Cancer in Kitchener High Risk Localized Prostate Cancer in London High Risk Localized Prostate Cancer in Halifax High Risk Localized Prostate Cancer in New York High Risk Localized Prostate Cancer in Los Angeles High Risk Localized Prostate Cancer in Chicago High Risk Localized Prostate Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease